Chinese medicine has gone out with a new strategy

The unveiling of the Institute of Medical Research of the Ling Medicine Institute of Leiden University in the Netherlands will probably become a best strategic path for China's Chinese medicine to “go global” and integrate into Western mainstream medical fields and markets. Earlier, the Institute of Ling Medicine and the Cardiff University in the United Kingdom set up the first medical research center. The industry generally believes that the Yiling Medical Research Institute, which is the base of the International Science and Technology Cooperation in Traditional Chinese Medicine of the Ministry of Science and Technology, is focusing on the study of collateral diseases in Chinese medicine to speed up the resolution of many difficulties encountered in current Western medicine.

It is understood that before the establishment of the medical research center with Leiden University in the Netherlands, the Institute of Ling Medicine and the University have reached a "study on the basis and mechanism of the treatment of chronic heart failure based on metabonomics". Project cooperation.

As one of the most prestigious European universities, the University of Leiden has nine universities, more than 50 departments, more than 150 majors, and 11 core research fields. It has trained 16 Nobel Prize winners.

According to reports, after the establishment of the new center, focusing on cardiovascular diseases, infectious diseases and other areas, the use of systems biology, reverse pharmacology cutting-edge technology methods, and continuously improve the theory of traditional Chinese medicine collaterals to guide the diagnosis and control of the above major clinical diseases .

Academician Wu Yiling, chairman of Yiling Pharmaceuticals, has established extensive cooperation and exchanges with Tongluo drugs with experts and scholars from South Korea, the United Kingdom, Sweden, and other countries after establishing the World Federation of Chinese Medicine Societies Federation of Diseases and Diseases Professional Committee. Disease research has a major impact on the world medical community.

It is reported that Yiling Pharmaceuticals is actively preparing for the establishment of the European Society for therapies and the Canadian Society for therapies.